Skip to main content
SpringerLink
Log in

Preeclampsia and Eclampsia: Nephrologist Perspective

  • Chapter
  • First Online:
Obstetric and Gynecologic Nephrology

  • 743 Accesses

Abstract

Preeclampsia is a heterogenous, systemic disorder that is caused by maternal and placental factors. Preexisting renal disease and chronic hypertension are significant risk factors for the development of preeclampsia, and the degree of renal insufficiency prior to pregnancy is an important determinant of the risk of maternal complications in pregnancy. While pregnancy itself may accelerate renal decline in some patients, it is not clear whether preeclampsia contributes additional damage. There are currently no clinically used biomarkers that can differentiate preeclampsia from intrinsic renal disease, and an interdisciplinary care approach is the best way to help manage these complex cases. There is evidence that preeclampsia is associated with the future low but increased risk of maternal renal disease. It is still unclear whether it is truly an independent risk factor, but preeclampsia may still identify women early in life who are at future risk of developing renal disease. The optimal long-term follow-up of women with preeclampsia is still not known, but providers should appreciate the significant overlap of renal disease and preeclampsia and have a high index of suspicion in women who do not follow a typical clinical course.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hypertension in pregnancyReport of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–31.

    Google Scholar 

  2. Maynard SE, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Craici IM, et al. Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int. 2014:275–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Williams D, Davison J. Chronic kidney disease in pregnancy. BMJ. 2008;336(7637):211–5.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hussain A, Karovitch A, Carson MP. Blood pressure goals and treatment in pregnant patients with chronic kidney disease. Adv Chronic Kidney Dis. 2015;22(2):165–9.

    Article  PubMed  Google Scholar 

  6. Karumanchi SA, et al. Preeclampsia: a renal perspective. Kidney Int. 2005;67(6):2101–13.

    Article  PubMed  Google Scholar 

  7. Sibai BM, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;339(10):667–71.

    Article  CAS  PubMed  Google Scholar 

  8. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lachmeijer AM, et al. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol. 2002;105(2):94–113.

    Article  CAS  PubMed  Google Scholar 

  10. Lie RT, et al. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ. 1998;316(7141):1343–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Walker JJ. Pre-eclampsia. Lancet. 2000;356(9237):1260–5.

    Article  CAS  PubMed  Google Scholar 

  12. Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med. 2002;346(1):33–8.

    Article  PubMed  Google Scholar 

  13. Trupin LS, Simon LP, Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology. 1996;7(3):240–4.

    Article  CAS  PubMed  Google Scholar 

  14. Robertson WB, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol. 1967;93(2):581–92.

    Article  CAS  PubMed  Google Scholar 

  15. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592–4.

    Article  CAS  PubMed  Google Scholar 

  16. Matthys LA, et al. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol. 2004;190(5):1464–6.

    Article  PubMed  Google Scholar 

  17. Levine RJ, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–83.

    Article  CAS  PubMed  Google Scholar 

  18. Zeisler H, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13–22.

    Article  CAS  PubMed  Google Scholar 

  19. Rana S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012;125(7):911–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Wilson M, et al. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med. 1980;68(1):97–104.

    Article  CAS  PubMed  Google Scholar 

  21. Granger JP, et al. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens. 2001;14(6 Pt 2):178S–85S.

    Article  CAS  PubMed  Google Scholar 

  22. Irani RA, Xia Y. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta. 2008;29(9):763–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Brown MA, Zammit VC, Mitar DM. Extracellular fluid volumes in pregnancy-induced hypertension. J Hypertens. 1992;10(1):61–8.

    Article  CAS  PubMed  Google Scholar 

  24. Wallukat G, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103(7):945–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Xia Y, et al. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig. 2003;10(2):82–93.

    Article  CAS  PubMed  Google Scholar 

  26. Zhou CC, et al. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension. 2008;51(4):1010–9.

    Article  CAS  PubMed  Google Scholar 

  27. Zhou CC, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med. 2008;14(8):855–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fisher KA, et al. Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine (Baltimore). 1981;60(4):267–76.

    Article  CAS  Google Scholar 

  29. Baylis C. The mechanism of the increase in glomerular filtration rate in the twelve-day pregnant rat. J Physiol. 1980;305:405–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Gallery ED, Gyory AZ. Glomerular and proximal renal tubular function in pregnancy-associated hypertension: a prospective study. Eur J Obstet Gynecol Reprod Biol. 1979;9(1):3–12.

    Article  CAS  PubMed  Google Scholar 

  31. Garovic VD, et al. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc – Eur Renal Assoc. 2007;22(4):1136–43.

    Article  CAS  Google Scholar 

  32. Garovic VD, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol. 2007;196(4):320 e1–7.

    Article  Google Scholar 

  33. Craici IM, et al. Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension. 2013;61(6):1289–96.

    Article  CAS  PubMed  Google Scholar 

  34. Penning ME, et al. Association of preeclampsia with podocyte turnover. Clin J Am Soc Nephrol. 2014;9(8):1377–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. White WM, et al. Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury. PLoS One. 2014;9(3):e92693.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Odutayo A, Hladunewich M. Obstetric nephrology: renal hemodynamic and metabolic physiology in Normal pregnancy. Clin J Am Soc Nephrol: CJASN. 2012;

    Google Scholar 

  37. Geback C, et al. Obstetrical outcome in women with urinary tract infections in childhood. Acta Obstet Gynecol Scand. 2016;95(4):452–7.

    Article  PubMed  Google Scholar 

  38. Hollowell JG. Outcome of pregnancy in women with a history of vesico-ureteric reflux. BJU Int. 2008;102(7):780–4.

    Article  PubMed  Google Scholar 

  39. Garg AX, et al. Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med. 2015;372(2):124–33.

    Article  CAS  PubMed  Google Scholar 

  40. Reisaeter AV, et al. Pregnancy and birth after kidney donation: the Norwegian experience. Am J Transplant. 2009;9(4):820–4.

    Article  CAS  PubMed  Google Scholar 

  41. Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med. 1996;335(4):226–32.

    Article  CAS  PubMed  Google Scholar 

  42. Imbasciati E, et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis. 2007;49(6):753–62.

    Article  PubMed  Google Scholar 

  43. Vikse BE, et al. Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrol Dial Transplant. 2010;25(10):3289–96.

    Article  PubMed  Google Scholar 

  44. Nevis IF, et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol: CJASN. 2011;6(11):2587–98.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Zhang JJ, et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin J Am Soc Nephrol: CJASN. 2015;

    Google Scholar 

  46. Levine RJ, et al. Trial of calcium to prevent preeclampsia. New Engl J Med. 1997;337(2):69–76.

    Article  CAS  PubMed  Google Scholar 

  47. Coomarasamy A, et al. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol. 2003;101(6):1319–32.

    CAS  PubMed  Google Scholar 

  48. Dekker GA, Sibai BM. Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials. Am J Obstet Gynecol. 1993;168(1 Pt 1):214–27.

    Article  CAS  PubMed  Google Scholar 

  49. Schramm AM, Clowse ME. Aspirin for prevention of preeclampsia in lupus pregnancy. Autoimmune Dis. 2014;2014:920467.

    PubMed  PubMed Central  Google Scholar 

  50. Rolnik D, Wirght D, Poon L, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–22.

    Article  CAS  PubMed  Google Scholar 

  51. Higby K, et al. Normal values of urinary albumin and total protein excretion during pregnancy. Am J Obstet Gynecol. 1994;171(4):984–9.

    Article  CAS  PubMed  Google Scholar 

  52. Rhee JS, Young BC, Rana S. Angiogenic factors and renal disease in pregnancy. Case Rep Obstet Gynecol. 2011;2011:281391.

    PubMed  PubMed Central  Google Scholar 

  53. Rolfo A, et al. Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers. Kidney Int. 2013;83(1):177–81.

    Article  CAS  PubMed  Google Scholar 

  54. von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can. 2002;24(12):941–5.

    Article  Google Scholar 

  55. Cooper WO, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443–51.

    Article  CAS  PubMed  Google Scholar 

  56. Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013;20(3):229–39.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Day C, et al. The role of renal biopsy in women with kidney disease identified in pregnancy. Nephrol Dial Transplant: Off Publ Eur Dial Transpl Assoc – Eur Renal Assoc. 2008;23(1):201–6.

    Article  Google Scholar 

  58. Chen HH, et al. Renal biopsy in pregnancies complicated by undetermined renal disease. Acta Obstet Gynecol Scand. 2001;80(10):888–93.

    Article  CAS  PubMed  Google Scholar 

  59. Vikse BE, et al. Adverse perinatal outcome and later kidney biopsy in the mother. J Am Soc Nephrol. 2006;17(3):837–45.

    Article  PubMed  Google Scholar 

  60. Vikse BE, et al. Preeclampsia and the risk of end-stage renal disease. New Engl J Med. 2008;359(8):800–9.

    Article  CAS  PubMed  Google Scholar 

  61. Murakami S, et al. Renal disease in women with severe preeclampsia or gestational proteinuria. Obstet Gynecol. 2000;96(6):945–9.

    CAS  PubMed  Google Scholar 

  62. Fisher KA, et al. Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine. 1981;60(4):267–76.

    Article  CAS  PubMed  Google Scholar 

  63. Kattah AG, et al. Hypertension in pregnancy is a risk factor for microalbuminuria later in life. J Clin Hypertens (Greenwich). 2013;15(9):617–23.

    Article  Google Scholar 

  64. McDonald SD, et al. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis. 2010;55(6):1026–39.

    Article  PubMed  Google Scholar 

  65. Mosca L, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57(12):1404–23.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Garovic VD, et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens. 2010;28(4):826–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Bellamy L, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Hypertension, Department of General Internal Medicine, Mayo Clinic, Rochester, MN, USA

    Andrea G. Kattah & Vesna D. Garovic

Authors
  1. Andrea G. Kattah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vesna D. Garovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vesna D. Garovic .

Editor information

Editors and Affiliations

  1. Division of Kidney Diseases and Hypertension, Department of Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, Great Neck, NY, USA

    Mala Sachdeva

  2. Division of Kidney Diseases and Hypertension, Department of Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, Great Neck, NY, USA

    Ilene Miller

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kattah, A.G., Garovic, V.D. (2020). Preeclampsia and Eclampsia: Nephrologist Perspective. In: Sachdeva, M., Miller, I. (eds) Obstetric and Gynecologic Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-25324-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25324-0_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25323-3

  • Online ISBN: 978-3-030-25324-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation